clinical dementia rating - sum of boxes (CDR-SB)
Jump to navigation
Jump to search
Introduction
Derived from Clinical Dementia Rating score
Procedure
- evaluates 6 domains of cognitive & functional performance:
- memory
- orientation
- judgment & problem solving
- community affairs
- home & hobbies
- personal care
* each domain is scored from 0 (normal) to 3 (severe impairment) the scores are summed to produce the CDR-SB score
Interpretation
- range 0-18, higher scores indicate greater impairment
- 0: No cognitive impairment
- 0.5 to 3.0: mild cognitive impairment
- 3.5 to 6.0: mild dementia
- 6.5 to 12.0: moderate dementia
- > 12.0: severe dementia
- score of 3.2 is consistent with early Alzheimer's disease
More general terms
Additional terms
References
- ↑ Yang YW, Hsu KC, Wei CY, Tzeng RC, Chiu PY. Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale. Front Aging Neurosci. 2021 Sep 7;13:705782. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34557083 PMCID: PMC8455062 Free PMC article.
- ↑ George J Alzheimer's Drug Slows Decline, Trial Data Show. Lecanemab met primary and secondary endpoints, but was associated with adverse events. MedPage Today November 30, 2022 https://www.medpagetoday.com/neurology/alzheimersdisease/101972
van Dyck CH, Swanson CJ, Aisen P Lecanemab in Early Alzheimer's Disease. N Engl J Med 2022. Nov 29. PMID: https://www.ncbi.nlm.nih.gov/pubmed/36449413 https://www.nejm.org/doi/full/10.1056/NEJMoa2212948